Rallybio Corp. (RLYB)

16.81 +0.05 (+0.30%) USD  |  NASDAQ  |  Aug 28, 16:00
16.84 +0.03 (+0.18%) After-Hours: 20:00
More

Rallybio Revenue Estimates for Next Quarter

Revenue Estimates for Next Quarter Chart

View Revenue Estimates for Next Quarter for RLYB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Next Quarter Chart
Start Trial

Historical Revenue Estimates for Next Quarter Data

View and export this data back to 2024. Start Trial.
Date Value
February 17, 2026 --
November 06, 2025 --
September 25, 2025 --
September 03, 2025 --
August 11, 2025 --
August 07, 2025 --
July 08, 2025 --
June 12, 2025 --
May 13, 2025 --
May 08, 2025 --
April 30, 2025 --
Date Value
April 14, 2025 --
April 09, 2025 --
April 08, 2025 --
March 14, 2025 --
August 29, 2024 --
August 09, 2024 --
May 15, 2024 --
May 10, 2024 --
April 21, 2024 --
April 11, 2024 --

Revenue Estimates for Next Quarter Range, Past 5 Years

View Revenue Estimates for Next Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Quarter Benchmarks

View Revenue Estimates for Next Quarter Benchmarks
Start Trial
Q32 Bio, Inc. Upgrade
Beam Therapeutics, Inc. Upgrade
C4 Therapeutics, Inc. Upgrade
Cullinan Therapeutics, Inc. Upgrade
Arrowhead Pharmaceuticals, Inc. Upgrade

Revenue Estimates for Next Quarter Related Metrics

EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade